Prognostic value of serial alactic base excess measurements in patients with sepsis: a retrospective cohort study
Frontiers in Medicine · 13.03.2026 · 13
DOI: 10.3389/fmed.2026.1755874 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Frontiers in Medicine, online erschienen am 13.03.2026. Verfasst von Dursun Elmas und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Division of Intensive Care, University of Health Sciences Türkiye, Konya City Hospital, Konya, Türkiye. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Sepsis
Abstract (Originalsprache)
Background
This study evaluated the prognostic significance of serial alactic base excess (ABE) measurements in patients with sepsis.
Methods
We conducted a retrospective cohort study including 521 adult patients with sepsis. Arterial blood gas analyses obtained at 0, 6, 12, 24, and 48 h were used to calculate ABE. Patients were classified into three trajectory groups: persistently low ABE (ABE < 0 at all time points), normalizing ABE (initial ABE < 0 with recovery to ≥0 by 48 h), and normal ABE (ABE ≥ 0 at admission). The primary outcome was 28-day mortality.
Results
Overall 28-day mortality was 35.9%. Non-survivors exhibited more severe metabolic derangement at admission, with higher lactate levels (median 4.22 [2.89–5.31] vs. 3.66 [2.31–4.82] mmol/L) and more negative base excess values (median −6.00 [−8.54 to −3.88] vs. −5.09 [−7.63 to −2.71] mmol/L) (both p < 0.001). Admission ABE was significantly lower in non-survivors and remained consistently reduced throughout the first 48 h (all p < 0.001). Patients with a persistently low ABE trajectory experienced the highest mortality compared with those whose ABE normalized (52.9% vs. 19.8%, p < 0.001). In multivariable Cox regression adjusted for age, sex, baseline eGFR, SOFA score, and APACHE II score, persistently low ABE independently predicted 28-day mortality (adjusted HR 2.539; 95% CI 1.510–4.267; p < 0.001). Furthermore, each 1 mmol/L increase in ΔABE over 48 h was associated with a 25% relative reduction in mortality risk (adjusted HR 0.750; 95% CI 0.633–0.889; p = 0.001). At ICU admission, ABE showed numerically higher discrimination for 28-day mortality than BE (AUC 0.671 vs. 0.639), although this difference did not reach statistical significance ( p = 0.057).
Conclusion
Serial ABE trajectories provide independent prognostic information in sepsis. Failure to normalize ABE within the first 48 h identifies a high-risk phenotype associated with markedly increased short-term mortality.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Division of Intensive Care, University of Health Sciences Türkiye, Konya City Hospital, Konya, Türkiye.
- Department of Internal Medicine, Division of Geriatrics, University of Health Sciences Türkiye, Konya City Hospital, Konya, Türkiye.
Zitieren
APA
Elmas, D., & Kizilarslanoglu, M. C. (2026). Prognostic value of serial alactic base excess measurements in patients with sepsis: a retrospective cohort study. Frontiers in Medicine, 13. https://doi.org/10.3389/fmed.2026.1755874
Vancouver
Elmas D, Kizilarslanoglu MC. Prognostic value of serial alactic base excess measurements in patients with sepsis: a retrospective cohort study. Frontiers in Medicine. 2026;13. doi:10.3389/fmed.2026.1755874
BibTeX
@article{Elmas2026,
author = {Elmas, Dursun and Kizilarslanoglu, Muhammet Cemal},
title = {Prognostic value of serial alactic base excess measurements in patients with sepsis: a retrospective cohort study},
journal = {Frontiers in Medicine},
year = {2026},
volume = {13},
doi = {10.3389/fmed.2026.1755874}
}
EUVIMED